BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. BMC Gastroenterol 2002;2:1. [PMID: 11866863 DOI: 10.1186/1471-230x-2-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Varma A, Weinstein J, Seabury J, Rosero S, Wagner E, Zizzi C, Luebbe E, Dilek N, McDermott M, Heatwole J, Saubermann L, Temple L, Rogoff S, Heatwole C. Patient-Reported Impact of Symptoms in Crohn's Disease. Am J Gastroenterol 2022;117:2033-45. [PMID: 36375002 DOI: 10.14309/ajg.0000000000001954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Alhadab AA, AlMahamed SN, Hassan IE, Hammo AH. The impact of inflammatory bowel diseases on the quality of life of Saudi pediatric patients: A cross-sectional study. Saudi J Gastroenterol 2022;28:448-55. [PMID: 35946259 DOI: 10.4103/sjg.sjg_162_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Monmousseau F, Mulot L, Rusch E, Picon L, Laharie D, Fotsing G, Gargot D, Charpentier C, Buisson A, Trang-Poisson C, Dib N, DES Garets V, Brunet-Houdard S, Aubourg A; COQC-PIT Study Group. Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristics. Scand J Gastroenterol 2022;57:566-73. [PMID: 35188859 DOI: 10.1080/00365521.2021.2025419] [Reference Citation Analysis]
4 Mendonça CM, Correa Neto IJF, Rolim ADS, Robles L. INFLAMMATORY BOWEL DISEASES: CHARACTERISTICS, EVOLUTION, AND QUALITY OF LIFE. ABCD, arq bras cir dig 2022;35. [DOI: 10.1590/0102-672020210002e1653] [Reference Citation Analysis]
5 Zavala-solares MR, Salazar-salas L, Yamamoto-furusho JK. Validity and reliability of the health-related questionnaire IBDQ-32 in Mexican patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 2021;44:711-718. [DOI: 10.1016/j.gastre.2021.03.005] [Reference Citation Analysis]
6 Graff LA, Fowler S, Jones JL, Benchimol EI, Bitton A, Huang JG, Kuenzig ME, Kaplan GG, Lee K, Mukhtar MS, Tandon P, Targownik LE, Windsor JW, Bernstein CN. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life. J Can Assoc Gastroenterol 2021;4:S46-53. [PMID: 34755039 DOI: 10.1093/jcag/gwab031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Straksyte V, Kiudelis G, Gineikiene I, Janciauskas D, Basevicius A, Lukosevicius S, Kupcinskas L. Lemann Index for Assessment of Crohn's Disease: Correlation with the Quality of Life, Endoscopic Disease Activity, Magnetic Resonance Index of Activity and C- Reactive Protein. Open Med (Wars) 2019;14:785-91. [PMID: 31737782 DOI: 10.1515/med-2019-0092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Min Ho PY, Hu W, Lee YY, Gao C, Tan YZ, Cheen HH, Wee HL, Lim TG, Ong WC. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res 2019;17:107-18. [PMID: 30419638 DOI: 10.5217/ir.2018.00099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
9 Jones JL, Nguyen GC, Benchimol EI, Bernstein CN, Bitton A, Kaplan GG, Murthy SK, Lee K, Cooke-Lauder J, Otley AR. The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life. J Can Assoc Gastroenterol 2019;2:S42-8. [PMID: 31294384 DOI: 10.1093/jcag/gwy048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
10 Willian MK, D'Haens G, Yarlas A, Joshi AV. Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study. J Patient Rep Outcomes 2018;2:22. [PMID: 30294708 DOI: 10.1186/s41687-018-0046-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Cotter TG, Binder M, Loftus EV Jr, Abboud R, McNally MA, Smyrk TC, Tremaine WJ, Sandborn WJ, Pardi DS. Development of a Microscopic Colitis Disease Activity Index: a prospective cohort study. Gut 2018;67:441-6. [PMID: 27965284 DOI: 10.1136/gutjnl-2016-313051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
12 Yarlas A, D'Haens G, Willian MK, Teynor M. Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study. Inflamm Bowel Dis 2018;24:450-63. [PMID: 29361097 DOI: 10.1093/ibd/izx041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
13 Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol 2017; 23(6): 1067-1075 [PMID: 28246481 DOI: 10.3748/wjg.v23.i6.1067] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
14 Tsoukka M, Jelastopulu E, Lavranos G, Charalambous G. Estimation of quality of life in Cypriot patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(1): 121-126 [PMID: 28104987 DOI: 10.3748/wjg.v23.i1.121] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Neilson K, Ftanou M, Monshat K, Salzberg M, Bell S, Kamm MA, Connell W, Knowles SR, Sevar K, Mancuso SG, Castle D. A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:694-701. [PMID: 26529560 DOI: 10.1097/MIB.0000000000000629] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
16 Alowais FA, Alferayan YA, Aljehani RM. Inflammatory Bowel Disease and Quality of Life in King Abdulaziz Medical City. OJGas 2016;06:11-16. [DOI: 10.4236/ojgas.2016.61003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 McCombie A, Gearry R, Andrews J, Mulder R, Mikocka-Walus A. Does Computerized Cognitive Behavioral Therapy Help People with Inflammatory Bowel Disease? A Randomized Controlled Trial. Inflamm Bowel Dis 2016;22:171-81. [PMID: 26360545 DOI: 10.1097/MIB.0000000000000567] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
18 McCombie AM, Mulder RT, Gearry RB. Coping Strategies and Psychological Outcomes of Patients with Inflammatory Bowel Disease in the First 6 Months After Diagnosis. Inflamm Bowel Dis 2015;21:2272-80. [PMID: 26099065 DOI: 10.1097/MIB.0000000000000476] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
19 Filipovic BR, Filipovic BF. Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(13): 3552-3563 [PMID: 24707138 DOI: 10.3748/wjg.v20.i13.3552] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 71] [Article Influence: 7.2] [Reference Citation Analysis]
20 Cohen BL, Zoëga H, Shah SA, Leleiko N, Lidofsky S, Bright R, Flowers N, Law M, Moniz H, Merrick M, Sands BE. Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. Aliment Pharmacol Ther 2014;39:811-22. [PMID: 24612278 DOI: 10.1111/apt.12659] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 9.7] [Reference Citation Analysis]
21 M'Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33-47. [PMID: 24833941 DOI: 10.4137/cgast.s12731] [Cited by in Crossref: 149] [Cited by in F6Publishing: 179] [Article Influence: 14.9] [Reference Citation Analysis]
22 Malik BA, Gibbons K, Spady D, Lees G, Otley A, Huynh HQ. Health-related quality of life in pediatric ulcerative colitis patients on conventional medical treatment compared to those after restorative proctocolectomy. Int J Colorectal Dis 2013;28:325-33. [PMID: 22914964 DOI: 10.1007/s00384-012-1561-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
23 Stephens NS, Siffledeen J, Su X, Murdoch TB, Fedorak RN, Slupsky CM. Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy. J Crohns Colitis 2013;7:e42-8. [PMID: 22626506 DOI: 10.1016/j.crohns.2012.04.019] [Cited by in Crossref: 82] [Cited by in F6Publishing: 92] [Article Influence: 8.2] [Reference Citation Analysis]
24 Hodgkins P, Yen L, Yarlas A, Karlstadt R, Solomon D, Kane S. Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis. Inflamm Bowel Dis 2013;19:386-96. [PMID: 22648999 DOI: 10.1002/ibd.23022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
25 Kalafateli M, Triantos C, Theocharis G, Giannakopoulou D, Koutroumpakis E, Chronis A, Sapountzis A, Margaritis V, Thomopoulos K, Nikolopoulou V. Health-related quality of life in patients with inflammatory bowel disease: a single-center experience. Ann Gastroenterol 2013;26:243-8. [PMID: 24714279] [Reference Citation Analysis]
26 Bennebroek Evertsz' F, Bockting CL, Stokkers PC, Hinnen C, Sanderman R, Sprangers MA. The effectiveness of cognitive behavioral therapy on the quality of life of patients with inflammatory bowel disease: multi-center design and study protocol (KL!C- study). BMC Psychiatry 2012;12:227. [PMID: 23237076 DOI: 10.1186/1471-244X-12-227] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
27 Horváth G, Farkas K, Hollósi R, Nagy F, Szepes Z, Papp M, Palatka K, Miheller P, Lakatos L, Szamosi T, Nyári T, Wittmann T, Molnár T. Is there any association between impaired health-related quality of life and non-adherence to medical therapy in inflammatory bowel disease? Scand J Gastroenterol 2012;47:1298-303. [PMID: 22935014 DOI: 10.3109/00365521.2012.703233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
28 Reinisch W, Sandborn WJ, Rutgeerts P, Feagan BG, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Blank M, Lang Y, Johanns J, Colombel JF, Present D, Sands BE. Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies. Inflamm Bowel Dis 2012;18:201-11. [PMID: 21484965 DOI: 10.1002/ibd.21697] [Cited by in Crossref: 147] [Cited by in F6Publishing: 120] [Article Influence: 13.4] [Reference Citation Analysis]
29 Stjernman H, Tysk C, Almer S, Ström M, Hjortswang H. Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. Eur J Gastroenterol Hepatol 2011;23:671-9. [PMID: 21654323 DOI: 10.1097/MEG.0b013e328346f622] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
30 Watanabe O, Ando T, Ishiguro K, Takahashi H, Ishikawa D, Miyake N, Kato T, Hibi S, Mimura S, Nakamura M, Miyahara R, Ohmiya N, Niwa Y, Goto H. Enteral nutrition decreases hospitalization rate in patients with Crohn's disease. J Gastroenterol Hepatol 2010;25 Suppl 1:S134-7. [PMID: 20586855 DOI: 10.1111/j.1440-1746.2010.06296.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
31 Hoivik ML, Bernklev T, Moum B. Need for standardization in population-based quality of life studies: a review of the current literature. Inflamm Bowel Dis 2010;16:525-36. [PMID: 19637337 DOI: 10.1002/ibd.21032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
32 Gili M, Bauzà N. [Quality of life and personality in inflammatory bowel disease]. Gastroenterol Hepatol 2009;32 Suppl 2:3-8. [PMID: 19900621 DOI: 10.1016/S0210-5705(09)72598-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Vogelaar L, Spijker AV, van der Woude CJ. The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clin Exp Gastroenterol. 2009;2:101-109. [PMID: 21694833 DOI: 10.2147/ceg.s4512] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
34 Elkjaer M, Moser G, Reinisch W, Durovicova D, Lukas M, Vucelic B, Wewer V, Frederic Colombel J, Shuhaibar M, O'Morain C, Politi P, Odes S, Bernklev T, Oresland T, Nikulina I, Belousova E, Van der Eijk I, Munkholm P. IBD patients need in health quality of care ECCO consensus. J Crohns Colitis 2008;2:181-8. [PMID: 21172209 DOI: 10.1016/j.crohns.2008.02.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
35 Irvine EJ. Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis 2008;14:554-65. [PMID: 17973299 DOI: 10.1002/ibd.20301] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
36 O’ R, Mccullough AJ. Immunomodulation Therapy for Alcoholic Hepatitis. Liver Immunology. [DOI: 10.1007/978-1-59745-518-3_26] [Reference Citation Analysis]
37 Akobeng AK. Review article: the evidence base for interventions used to maintain remission in Crohn's disease. Aliment Pharmacol Ther 2008;27:11-8. [PMID: 17919275 DOI: 10.1111/j.1365-2036.2007.03536.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
38 Feagan BG, Reinisch W, Rutgeerts P, Sandborn WJ, Yan S, Eisenberg D, Bala M, Johanns J, Olson A, Hanauer SB. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol 2007;102:794-802. [PMID: 17324131 DOI: 10.1111/j.1572-0241.2007.01094.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 121] [Article Influence: 7.1] [Reference Citation Analysis]
39 Kunzendorf S, Jantschek G, Straubinger K, Heberlein I, Homann N, Ludwig D, Benninghoven D. The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:33-41. [PMID: 17206637 DOI: 10.1002/ibd.20050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
40 Faresjö A, Anastasiou F, Lionis C, Johansson S, Wallander MA, Faresjö T. Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health Qual Life Outcomes 2006;4:21. [PMID: 16566821 DOI: 10.1186/1477-7525-4-21] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
41 Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;21:499-508. [PMID: 15740531 DOI: 10.1111/j.1365-2036.2005.02380.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 82] [Article Influence: 5.6] [Reference Citation Analysis]
42 Alcalá MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis 2004;10:383-91. [PMID: 15475746 DOI: 10.1097/00054725-200407000-00009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
43 Pallis AG, Vlachonikolis IG, Mouzas IA. Validation of a reliable instrument (QUOTE-IBD) for assessing the quality of health care in Greek patients with inflammatory bowel disease. Digestion 2003;68:153-60. [PMID: 14671422 DOI: 10.1159/000075524] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
44 Tountas Y, Demakakos PT, Yfantopoulos Y, Aga J, Houliara L, Pavi E. The health related quality of life of the employees in the Greek hospitals: assessing how healthy are the health workers. Health Qual Life Outcomes 2003;1:61. [PMID: 14613561 DOI: 10.1186/1477-7525-1-61] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
45 Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2003;15:1011-20. [PMID: 12923375 DOI: 10.1097/00042737-200309000-00012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 3.2] [Reference Citation Analysis]